Skye Bioscience

SKYE · NASDAQ

$1.62+$0.09 (+5.88%)TodayMarket closed ·
Prev close $1.53

Who owns SKYE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 5.9% of SKYE’s shares.

  • 5AM Ventures3.3%
  • Versant Ventures0.7%
  • Baker Bros. Advisors LP0.6%
  • Dhillon (Punit S)0.4%
  • Next 6 largest institutions0.8%
  • All other shareholders94.1%
Top institutional holders of SKYE
HolderShares% of shares
5AM Ventures1.17M3.34%
Versant Ventures250.96K0.71%
Baker Bros. Advisors LP196.91K0.56%
Dhillon (Punit S)157.89K0.45%
Vanguard Capital Management, LLC95.48K0.27%
Sphera Funds Management Ltd.84.87K0.24%
Platinum Asset Management29.14K0.08%
BlackRock Institutional Trust Company, N.A.29.11K0.08%
Geode Capital Management, L.L.C.27.26K0.08%
Millennium Management LLC24.82K0.07%

Largest mutual fund holders

Top mutual fund holders of SKYE
HolderShares% of shares
Vanguard Total Stock Market Index Fund70.23K0.20%
Platinum International Health Sciences Fund29.14K0.08%
Vanguard Extended Market Index Fund23.12K0.07%
Fidelity Extended Market Index Fund14.02K0.04%
Fidelity Total Market Index Fund3.83K0.01%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $889.20K (30 trades) of SKYE on the open market, with no buys.

Latest SKYE insider transactions
InsiderTypeSharesValue
Schwab Andrew J.Sale4.53K$7.29K
Schwab Andrew J.Sale114.85K$184.91K
5AM Partners VII, LLCSale4.53K$7.29K
5AM Partners VII, LLCSale114.85K$184.91K
Schwab Andrew J.Sale1.09K$1.80K
Schwab Andrew J.Sale27.61K$45.56K
5AM Partners VII, LLCSale1.09K$1.80K
5AM Partners VII, LLCSale27.61K$45.56K
Schwab Andrew J.Sale1.28K$2.45K
Schwab Andrew J.Sale32.61K$62.28K

Short interest

Settled Sep 30, 2026

Shares short
147.95K
Days to cover
1.74
% of shares outstanding
0.42%
Average daily volume
85.21K
Change since last report
+26.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.